1. Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer
   Xiuqin Zhang et al, 2024, Technology in Cancer Research & Treatment CrossRef
2. Spatiotemporal Control of Inflammatory Lytic Cell Death Through Optogenetic Induction of RIPK3 Oligomerization
   Teak-Jung Oh et al, 2024, Journal of Molecular Biology CrossRef
3. The Importance of HHLA2 in Solid Tumors—A Review of the Literature
   Agnieszka Kula et al, 2024, Cells CrossRef
4. Overexpression and Role of HHLA2, a Novel Immune Checkpoint, in Colorectal Cancer
   Agnieszka Kula et al, 2023, International Journal of Molecular Sciences CrossRef
5. HHLA2 promotes hepatoma cell proliferation, migration, and invasion via SPP1/PI3K/AKT signaling pathway
   Junqi Wang et al, 2024, Molecular Carcinogenesis CrossRef
6. Dendritic cell vaccination strategy for the treatment of acute myeloid leukemia: a systematic review
   Jamal Motallebzadeh Khanmiri et al, 2024, Cytotherapy CrossRef
7. Prognostic Value of HHLA2 in Patients with Solid Tumors: A Meta-Analysis
   Agnieszka Kula et al, 2024, International Journal of Molecular Sciences CrossRef
8. Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands
   Ali N. Kamali et al, 2023, Therapeutic Advances in Vaccines and Immunotherapy CrossRef
9. Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: A review focus on signaling pathways interplay
   Ahmed S. Doghish et al, 2024, International Journal of Biological Macromolecules CrossRef